Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 4
2009 7
2010 14
2011 19
2012 28
2013 23
2014 24
2015 20
2016 14
2017 15
2018 14
2019 6
2020 10
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E, Montes JM. Vieta E, et al. Clin Drug Investig. 2018 Feb;38(2):87-99. doi: 10.1007/s40261-017-0592-2. Clin Drug Investig. 2018. PMID: 29067671 Free PMC article. Review.
The most common adverse events associated with asenapine are somnolence, dizziness, extrapyramidal symptoms, increased bodyweight and oral hypoesthesia. ...Economic analyses indicate that the use of asenapine can, over time, lead to a reduction in the costs o …
The most common adverse events associated with asenapine are somnolence, dizziness, extrapyramidal symptoms, increased bodywei …
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.
Mauri MC, Paletta S, Di Pace C, Reggiori A, Cirnigliaro G, Valli I, Altamura AC. Mauri MC, et al. Clin Pharmacokinet. 2018 Dec;57(12):1493-1528. doi: 10.1007/s40262-018-0664-3. Clin Pharmacokinet. 2018. PMID: 29915922 Review.
Therapeutic drug monitoring studies have generally concentrated on controlling compliance and avoiding side effects by maintaining long-term exposure to minimally effective blood concentrations. ...This review concentrates on the clinical pharmacokinetic data related to cl …
Therapeutic drug monitoring studies have generally concentrated on controlling compliance and avoiding side effects by maintaining lo …
Asenapine.
Weber J, McCormack PL. Weber J, et al. CNS Drugs. 2009 Sep;23(9):781-92. doi: 10.2165/11200860-000000000-00000. CNS Drugs. 2009. PMID: 19689168 Review.
It is being developed for the treatment of schizophrenia and bipolar mania. In two randomized, controlled trials of asenapine monotherapy and in one randomized, controlled trial of adjunctive asenapine therapy in adult patients with bipolar I disorder, sublingual …
It is being developed for the treatment of schizophrenia and bipolar mania. In two randomized, controlled trials of asenapine monothe …
Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
Bozzatello P, Rocca P, Uscinska M, Bellino S. Bozzatello P, et al. CNS Drugs. 2017 Sep;31(9):809-819. doi: 10.1007/s40263-017-0458-4. CNS Drugs. 2017. PMID: 28741044 Free article. Clinical Trial.
CONCLUSIONS: Asenapine and olanzapine were demonstrated to have a similar efficacy. While asenapine was found to be more efficacious than olanzapine in treating affective instability, olanzapine was superior to asenapine in treating paranoid ideation and diss …
CONCLUSIONS: Asenapine and olanzapine were demonstrated to have a similar efficacy. While asenapine was found to be more effic …
Asenapine for the Treatment of Psychotic Disorders.
Orr C, Deshpande S, Sawh S, Jones PM, Vasudev K. Orr C, et al. Can J Psychiatry. 2017 Feb;62(2):123-137. doi: 10.1177/0706743716661324. Epub 2016 Aug 6. Can J Psychiatry. 2017. PMID: 27481921 Free PMC article. Review.
No differences were found between asenapine and olanzapine in rates of discontinuation due to adverse drug reactions or lack of efficacy, but those taking asenapine had higher rates of withdrawal for any reason than those taking olanzapine. ...While asenap
No differences were found between asenapine and olanzapine in rates of discontinuation due to adverse drug reactions or lack o …
Asenapine: A Review in Schizophrenia.
Plosker GL, Deeks ED. Plosker GL, et al. CNS Drugs. 2016 Jul;30(7):655-66. doi: 10.1007/s40263-016-0363-2. CNS Drugs. 2016. PMID: 27356921 Review.
The most frequently reported adverse events with asenapine are somnolence, akathisia and oral hypoesthesia. Although potentially associated with more extrapyramidal symptoms, asenapine appears to have less weight gain and metabolic effects than some ot …
The most frequently reported adverse events with asenapine are somnolence, akathisia and oral hypoesthesia. Although potential …
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.
Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF. Solmi M, et al. Ther Clin Risk Manag. 2017 Jun 29;13:757-777. doi: 10.2147/TCRM.S117321. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 28721057 Free PMC article. Review.
However, treatment with SGAs has been associated with a wide range of untoward effects, among which treatment-emergent weight gain and metabolic abnormalities are of notable concern. The present clinical review aims to summarize the safety and tolerability profile of selec …
However, treatment with SGAs has been associated with a wide range of untoward effects, among which treatment-emergent weight gain an …
Asenapine for the treatment of bipolar disorder.
Marazziti D, Mucci F, Falaschi V, Dell'Osso L. Marazziti D, et al. Expert Opin Pharmacother. 2019 Aug;20(11):1321-1330. doi: 10.1080/14656566.2019.1617849. Epub 2019 May 27. Expert Opin Pharmacother. 2019. PMID: 31132287 Review.
Its tolerability profile is good, and its most common side effects are somnolence, light extrapyramidal symptoms, dizziness, weight gain, and oral (but reversible) hypoesthesia. Taken together, the published studies indicate that asenapine might be an effective ther …
Its tolerability profile is good, and its most common side effects are somnolence, light extrapyramidal symptoms, dizziness, weight g …
Asenapine.
Meltzer HY, Dritselis A, Yasothan U, Kirkpatrick P. Meltzer HY, et al. Nat Rev Drug Discov. 2009 Nov;8(11):843-4. doi: 10.1038/nrd3027. Nat Rev Drug Discov. 2009. PMID: 19876039
In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults....
In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or …
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review.
Damkier P, Videbech P. Damkier P, et al. CNS Drugs. 2018 Apr;32(4):351-366. doi: 10.1007/s40263-018-0517-5. CNS Drugs. 2018. PMID: 29637530 Review.
Safety data on ziprasidone and clozapine remain scarce and insufficient for a quantitative safety evaluation. No or minimal safety data are available for amisulpride, asenapine, lurasidone, and sertindole. For other pregnancy outcomes of interest, e.g. miscarriage, stillbi …
Safety data on ziprasidone and clozapine remain scarce and insufficient for a quantitative safety evaluation. No or minimal safety data are …
182 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page